Details of the Drug Reposition

General Information of This Drug (ID: DMI0GZT)

• Drug Name: MAGE-A3 immunotherapeutic (DMI0GZT)

Information on Drug Reposition of This Drug

3 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Phase 3	[1]
Melanoma	DIS1RRCY	2C30	Phase 3	[1]
Type-2 diabetes	DIS3X247	5A11	Phase 3	[1]

References

• [1] Clinical pipeline report, company report or official report of GlaxoSmithKline.